-+ 0.00%
-+ 0.00%
-+ 0.00%

ALX Oncology Holdings Q3 Adj. EPS $(0.13) Beats $(0.14) Estimate

Benzinga·11/16/2026 13:35:14
Listen to the news
ALX Oncology Holdings (NASDAQ:ALXO) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 7.14 percent. This is a 63.89 percent increase over losses of $(0.36) per share from the same period last year.